In the Media Tag: Athena Starlard-Davenport

UTHSC’s Athena Starlard-Davenport awarded NIH grant to study potential sickle cell treatment pathway

Published by The Memphis Business Journal
The Memphis Business Journal

In a century’s worth of drug approvals, only four sickle cell disease treatments have received Food and Drug Administration (FDA) approval. A University of Tennessee Health Science Center (UTHSC) researcher hopes her work will help increase that number. Athena Starlard-Davenport, Ph.D., was awarded a three-year, $900,000-plus National Institutes of Health (NIH) grant to serve as… Read More

Starlard-Davenport awarded nearly $1 million for sickle cell research 

Published by EurekAlert!
In the Media Icon

A new research project that could impact and expand the discovery of new treatment options for sickle cell patients has received significant federal funding. The National Heart, Lung, and Blood Institute awarded nearly $1 million to Athena Starlard-Davenport, PhD, assistant professor of Genetics, Genomics, and Informatics in the UTHSC College of Medicine, for her project… Read More